{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:00:35Z","timestamp":1777417235897,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10555-019-09826-0","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T14:02:42Z","timestamp":1575554562000},"page":"771-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7531-2840","authenticated-orcid":false,"given":"Wafaa M.","family":"Rashed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa","family":"Matboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherin I.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"issue":"1","key":"9826_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ped.13457","volume":"60","author":"M Kato","year":"2018","unstructured":"Kato, M., & Manabe, A. (2018). Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatrics International, 60(1), 4\u201312. https:\/\/doi.org\/10.1111\/ped.13457.","journal-title":"Pediatrics International"},{"issue":"23","key":"9826_CR2","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1200\/JCO.2014.55.6571","volume":"32","author":"MM Hudson","year":"2014","unstructured":"Hudson, M. M., Link, M. P., & Simone, J. V. (2014). Milestones in the curability of pediatric cancers. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 32(23), 2391\u20132397. https:\/\/doi.org\/10.1200\/JCO.2014.55.6571.","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"9826_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/asheducation-2012.1.129","volume":"2012","author":"EA Raetz","year":"2012","unstructured":"Raetz, E. A., & Bhatla, T. (2012). Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? Hematology. American Society of Hematology. Education Program, 2012, 129\u2013136. https:\/\/doi.org\/10.1182\/asheducation-2012.1.129.","journal-title":"Hematology. American Society of Hematology. Education Program"},{"key":"9826_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fgene.2019.00478","volume":"10","author":"J Hanna","year":"2019","unstructured":"Hanna, J., Hossain, G. S., & Kocerha, J. (2019). The potential for microRNA therapeutics and clinical research. Frontiers in Genetics, 10, 478. https:\/\/doi.org\/10.3389\/fgene.2019.00478.","journal-title":"Frontiers in Genetics"},{"issue":"1","key":"9826_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-019-1180-5","volume":"38","author":"GED Petrescu","year":"2019","unstructured":"Petrescu, G. E. D., Sabo, A. A., Torsin, L. I., Calin, G. A., & Dragomir, M. P. (2019). MicroRNA based theranostics for brain cancer: basic principles. Journal of Experimental & Clinical Cancer Research, 38(1), 231. https:\/\/doi.org\/10.1186\/s13046-019-1180-5.","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"6","key":"9826_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/15476286.2019.1593094","volume":"16","author":"R Fan","year":"2019","unstructured":"Fan, R., Xiao, C., Wan, X., Cha, W., Miao, Y., Zhou, Y., Qin, C., Cui, T., Su, F., & Shan, X. (2019). Small molecules with big roles in microRNA chemical biology and microRNA-targeted therapeutics. RNA Biology, 16(6), 707\u2013718. https:\/\/doi.org\/10.1080\/15476286.2019.1593094.","journal-title":"RNA Biology"},{"key":"9826_CR7","unstructured":"Bonneau, E., Neveu, B., Kostantin, E., Tsongalis, G. J., & De Guire, V. (2019). How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. EJIFCC, 30(2), 114\u2013127. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31263388"},{"issue":"W1","key":"9826_CR8","doi-asserted-by":"publisher","first-page":"W460","DOI":"10.1093\/nar\/gkv403","volume":"43","author":"IS Vlachos","year":"2015","unstructured":"Vlachos, I. S., Zagganas, K., Paraskevopoulou, M. D., Georgakilas, G., Karagkouni, D., Vergoulis, T., Dalamagas, T., & Hatzigeorgiou, A. G. (2015). DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Research, 43(W1), W460\u2013W466. https:\/\/doi.org\/10.1093\/nar\/gkv403.","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"9826_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/bjh.12489","volume":"163","author":"J Yan","year":"2013","unstructured":"Yan, J., Jiang, N., Huang, G., Tay, J. L.-S., Lin, B., Bi, C., et al. (2013). Deregulated MIR335 that targets MAPK1 is implicated in poor outcome of paediatric acute lymphoblastic leukaemia. British Journal of Haematology, 163(1), 93\u2013103. https:\/\/doi.org\/10.1111\/bjh.12489.","journal-title":"British Journal of Haematology"},{"issue":"12","key":"9826_CR10","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.3109\/10428194.2012.685731","volume":"53","author":"Neda Mosakhani","year":"2012","unstructured":"Mosakhani, N., Sarhadi, V. K., Usvasalo, A., Karjalainen-Lindsberg, M.-L., Lahti, L., Tuononen, K., \u2026 Knuutila, S. (2012). MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic tools. Leukemia & Lymphoma. England. doi:https:\/\/doi.org\/10.3109\/10428194.2012.685731","journal-title":"Leukemia & Lymphoma"},{"issue":"4","key":"9826_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/gcc.22334","volume":"55","author":"S Avigad","year":"2016","unstructured":"Avigad, S., Verly, I. R. N., Lebel, A., Kordi, O., Shichrur, K., Ohali, A., et al. (2016). miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia. Genes, Chromosomes & Cancer, 55(4), 328\u2013339. https:\/\/doi.org\/10.1002\/gcc.22334.","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"24","key":"9826_CR12","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1093\/hmg\/ddr428","volume":"20","author":"B-W Han","year":"2011","unstructured":"Han, B.-W., Feng, D.-D., Li, Z.-G., Luo, X.-Q., Zhang, H., Li, X.-J., Zhang, X. J., Zheng, L. L., Zeng, C. W., Lin, K. Y., Zhang, P., Xu, L., & Chen, Y.-Q. (2011). A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL. Human Molecular Genetics, 20(24), 4903\u20134915. https:\/\/doi.org\/10.1093\/hmg\/ddr428.","journal-title":"Human Molecular Genetics"},{"issue":"5","key":"9826_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3324\/haematol.2010.026138","volume":"96","author":"D Schotte","year":"2011","unstructured":"Schotte, D., de Menezes, R. X., Moqadam, F. A., Khankahdani, L. M., Lange-Turenhout, E., Chen, C., et al. (2011). MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia. Haematologica, 96(5), 703\u2013711. https:\/\/doi.org\/10.3324\/haematol.2010.026138.","journal-title":"Haematologica"},{"issue":"3","key":"9826_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.leukres.2011.10.005","volume":"36","author":"JC de Oliveira","year":"2012","unstructured":"de Oliveira, J. C., Scrideli, C. A., Brassesco, M. S., Morales, A. G., Pezuk, J. A., Queiroz, R. d. P., et al. (2012). Differential MiRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features. Leukemia Research, 36(3), 293\u2013298. https:\/\/doi.org\/10.1016\/j.leukres.2011.10.005.","journal-title":"Leukemia Research"},{"issue":"4","key":"9826_CR15","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3892\/or.2015.3787","volume":"33","author":"J Organista-Nava","year":"2015","unstructured":"Organista-Nava, J., G\u00f3mez-G\u00f3mez, Y., Illades-Aguiar, B., Del Carmen Alarc\u00f3n-Romero, L., Saavedra-Herrera, M. V., Rivera-Ram\u00edrez, A. B., et al. (2015). High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia. Oncology Reports, 33(4), 1639\u20131649. https:\/\/doi.org\/10.3892\/or.2015.3787.","journal-title":"Oncology Reports"},{"issue":"8","key":"9826_CR16","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/bjc.2013.562","volume":"109","author":"XJ Li","year":"2013","unstructured":"Li, X. J., Luo, X. Q., Han, B. W., Duan, F. T., Wei, P. P., & Chen, Y. Q. (2013). MicroRNA-100\/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R\/mTOR signalling pathways. British Journal of Cancer, 109(8), 2189\u20132198. https:\/\/doi.org\/10.1038\/bjc.2013.562.","journal-title":"British Journal of Cancer"},{"issue":"7","key":"9826_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/10245332.2017.1292204","volume":"22","author":"HA Labib","year":"2017","unstructured":"Labib, H. A., Elantouny, N. G., Ibrahim, N. F., & Alnagar, A. A. (2017). Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia. Hematology (Amsterdam, Netherlands), 22(7), 392\u2013397. https:\/\/doi.org\/10.1080\/10245332.2017.1292204.","journal-title":"Hematology (Amsterdam, Netherlands)"},{"issue":"7","key":"9826_CR18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00277-018-3292-y","volume":"97","author":"D Piatopoulou","year":"2018","unstructured":"Piatopoulou, D., Avgeris, M., Drakaki, I., Marmarinos, A., Xagorari, M., Baka, M., Pourtsidis, A., Kossiva, L., Gourgiotis, D., & Scorilas, A. (2018). Clinical utility of miR-143\/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia. Annals of Hematology, 97(7), 1169\u20131182. https:\/\/doi.org\/10.1007\/s00277-018-3292-y.","journal-title":"Annals of Hematology"},{"issue":"6","key":"9826_CR19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/bjc.2017.256","volume":"117","author":"D Piatopoulou","year":"2017","unstructured":"Piatopoulou, D., Avgeris, M., Marmarinos, A., Xagorari, M., Baka, M., Doganis, D., Kossiva, L., Scorilas, A., & Gourgiotis, D. (2017). miR-125b predicts childhood acute lymphoblastic leukaemia poor response to BFM chemotherapy treatment. British Journal of Cancer, 117(6), 801\u2013812. https:\/\/doi.org\/10.1038\/bjc.2017.256.","journal-title":"British Journal of Cancer"},{"issue":"9","key":"9826_CR20","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.leukres.2008.12.015","volume":"33","author":"T Kaddar","year":"2009","unstructured":"Kaddar, T., Chien, W. W., Bertrand, Y., Pages, M. P., Rouault, J. P., Salles, G., et al. (2009). Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation. Leukemia Research, 33(9), 1217\u20131223. https:\/\/doi.org\/10.1016\/j.leukres.2008.12.015.","journal-title":"Leukemia Research"},{"issue":"10","key":"9826_CR21","doi-asserted-by":"publisher","first-page":"4443","DOI":"10.1158\/0008-5472.CAN-08-4025","volume":"69","author":"X Agirre","year":"2009","unstructured":"Agirre, X., Vilas-Zornoza, A., Jimenez-Velasco, A., Martin-Subero, J. I., Cordeu, L., Garate, L., et al. (2009). Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Research, 69(10), 4443\u20134453. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4025.","journal-title":"Cancer Research"},{"issue":"1","key":"9826_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","volume":"177","author":"G Sirugo","year":"2019","unstructured":"Sirugo, G., Williams, S. M., & Tishkoff, S. A. (2019). The missing diversity in human genetic studies. Cell, 177(1), 26\u201331. https:\/\/doi.org\/10.1016\/j.cell.2019.02.048.","journal-title":"Cell"},{"issue":"1","key":"9826_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.pcl.2014.09.006","volume":"62","author":"SL Cooper","year":"2015","unstructured":"Cooper, S. L., & Brown, P. A. (2015). Treatment of pediatric acute lymphoblastic leukemia. Pediatric Clinics of North America, 62(1), 61\u201373. https:\/\/doi.org\/10.1016\/j.pcl.2014.09.006.","journal-title":"Pediatric Clinics of North America"},{"issue":"S1","key":"9826_CR24","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","volume":"11","author":"S Schmidt","year":"2004","unstructured":"Schmidt, S., Rainer, J., Ploner, C., Presul, E., Riml, S., & Kofler, R. (2004). Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death and Differentiation, 11(S1), S45\u2013S55. https:\/\/doi.org\/10.1038\/sj.cdd.4401456.","journal-title":"Cell Death and Differentiation"},{"issue":"6","key":"9826_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.3892\/ijo.21.6.1339","volume":"21","author":"E Groninger","year":"2002","unstructured":"Groninger, E., Meeuwsen-De Boer, G., De Graaf, S., Kamps, W., & De Bont, E. (2002). Vincristine induced apoptosis in acute lymphoblastic leukaemia cells: a mitochondrial controlled pathway regulated by reactive oxygen species? International Journal of Oncology, 21(6), 1339\u20131345. https:\/\/doi.org\/10.3892\/ijo.21.6.1339.","journal-title":"International Journal of Oncology"},{"key":"9826_CR26","unstructured":"Richardson, D. S., & Johnson, S. A. (1997). Anthracyclines in haematology: preclinical studies, toxicity and delivery systems. Blood Reviews, 11(4), 201\u201323. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9481450."},{"issue":"39","key":"9826_CR27","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A Cimmino","year":"2005","unstructured":"Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., Rassenti, L., Alder, H., Volinia, S., Liu, C. G., Kipps, T. J., Negrini, M., & Croce, C. M. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proceedings of the National Academy of Sciences, 102(39), 13944\u201313949. https:\/\/doi.org\/10.1073\/pnas.0506654102.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"9826_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1182\/blood-2014-05-576470","volume":"125","author":"D Jing","year":"2015","unstructured":"Jing, D., Bhadri, V. A., Beck, D., Thoms, J. A. I., Yakob, N. A., Wong, J. W. H., et al. (2015). Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells. Blood, 125(2), 273\u2013283. https:\/\/doi.org\/10.1182\/blood-2014-05-576470.","journal-title":"Blood"},{"issue":"11","key":"9826_CR29","doi-asserted-by":"publisher","first-page":"e7826","DOI":"10.1371\/journal.pone.0007826","volume":"4","author":"H Zhang","year":"2009","unstructured":"Zhang, H., Luo, X.-Q., Zhang, P., Huang, L.-B., Zheng, Y.-S., Wu, J., et al. (2009). MicroRNA patterns associated with clinical prognostic parameters and CNS relapse prediction in pediatric acute leukemia. PLoS One, 4(11), e7826. https:\/\/doi.org\/10.1371\/journal.pone.0007826.","journal-title":"PLoS One"},{"issue":"4","key":"9826_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/cas.12370","volume":"105","author":"Y Mei","year":"2014","unstructured":"Mei, Y., Gao, C., Wang, K., Cui, L., Li, W., Zhao, X., Liu, F., Wu, M., Deng, G., Ding, W., Jia, H., & Li, Z. (2014). Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia. Cancer Science, 105(4), 463\u2013472. https:\/\/doi.org\/10.1111\/cas.12370.","journal-title":"Cancer Science"},{"issue":"6","key":"9826_CR31","doi-asserted-by":"publisher","first-page":"8072","DOI":"10.3892\/ol.2017.7229","volume":"14","author":"Y Mei","year":"2017","unstructured":"Mei, Y., Li, Z., Zhang, Y., Zhang, W., Hu, H., Zhang, P., Wu, M., & Huang, D. (2017). Low miR-210 and CASP8AP2 expression is associated with a poor outcome in pediatric acute lymphoblastic leukemia. Oncology Letters, 14(6), 8072\u20138077. https:\/\/doi.org\/10.3892\/ol.2017.7229.","journal-title":"Oncology Letters"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-019-09826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-019-09826-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-019-09826-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:21:40Z","timestamp":1607041300000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-019-09826-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9826"],"URL":"https:\/\/doi.org\/10.1007\/s10555-019-09826-0","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"5 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}